NEW YORK (GenomeWeb) – PointCross Life Sciences today announced a strategic partnership to integrate its RDIS data platform with InterpretOmics iOmics genomic analysis software tools.

The partners will work together to analyze genomic biomarkers collected in clinical trials and other studies.

"The integration of our RDIS platform with iOmics allows us to address critical industry needs with a visionary integration capable of exploiting diverse data types to identify important safety and efficacy signals," PointCross VP Shree Nath said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Customers might want to consider what they might learn about their risk of diseases like Alzheimer's before snagging the genetic testing kits that are on many gift guides this year, NJ.com writes.

The Wall Street Journal reports there is uncertainty surrounding whether He Jiankui's embryo editing did what he said it did.

Stat News reports that the pause on procuring fetal tissue for intramural US National Institutes of Health research will soon affect additional labs there.

In Nature this week: genomic analysis of the invasive fall webworm, amp of constrained coding regions within the human genome, and more.